Table 3.
Adverse events of previous vaccination by intention to receive the booster dose of the COVID-19 vaccine.
| Adverse Events/Yes | Acceptance n = 4832 n (%) |
Not Sure n = 925 n (%) |
Hesitancy n = 415 n (%) |
p-Value * |
|---|---|---|---|---|
| Lumps at the vaccination site | 870 (18.0) | 155 (16.8) | 58 (14.0) | 0.093 |
| Itching at the vaccination site | 626 (13.0) | 144 (15.6) | 64 (15.4) | 0.052 |
| Pain at the vaccination site | 3210 (66.4) | 632 (68.3) | 275 (66.3) | 0.525 |
| Redness at the vaccination site | 979 (20.3) | 198 (21.4) | 79 (19.0) | 0.577 |
| Swelling of the inoculation site | 1517 (31.4) | 299 (32.3) | 152 (36.6) | 0.086 |
| Fever | 2142 (44.3) | 517 (55.9) | 259 (62.4) | <0.001 |
| Tiredness, fatigue | 2039 (42.2) | 491 (53.1) | 234 (56.4) | <0.001 |
| Headache | 1036 (21.4) | 293 (31.7) | 157 (37.8) | <0.001 |
| Chills | 534 (11.1) | 167 (18.1) | 97 (23.4) | <0.001 |
| Vomiting | 64 (1.3) | 24 (2.6) | 17 (4.1) | <0.001 |
| Diarrhea | 80 (1.7) | 19 (2.1) | 24 (5.8) | <0.001 |
| Muscular pain | 1092 (22.6) | 266 (28.8) | 149 (35.9) | <0.001 |
| Arthralgia | 450 (9.3) | 148 (16.0) | 87 (21.0) | <0.001 |
| Anaphylactic shock | 11 (0.2) | 3 (0.3) | 5 (1.2) | 0.003 |
| None | 457 (9.5) | 76 (8.2) | 30 (7.2) | 0.186 |
* p-values were calculated using the 3 × 2 χ2 test.